EC-234/OC-229

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameEC-234/OC-229
Drug Alias NameOC-229/EC-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitorsSelectins inhibitors
TargetsSelectinsTumor necrosis factor
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomedica Management Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomedica Management Co
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A